-
miR-18a/ALOXE3 Axis Regulates Ferroptosis in Glioblastoma
2026-05-13
This study uncovers a novel tumor-promoting mechanism in glioblastoma, where miR-18a downregulates ALOXE3, suppressing ferroptosis and enhancing cell migration. The findings highlight the miR-18a/ALOXE3 pathway as a promising therapeutic target and provide mechanistic insight into lipid metabolism’s role in glioma progression.
-
NLRP10 Regulates Keratinocyte Survival and Skin Barrier in A
2026-05-13
This study reveals that NLRP10 is essential for epidermal homeostasis by promoting keratinocyte survival and p63-dependent differentiation, thereby maintaining skin barrier function in atopic dermatitis (AD). The work provides mechanistic insight into how genetic variation at the NLRP10 locus contributes to AD pathology and highlights NLRP10 as a promising therapeutic target for restoring barrier integrity.
-
SC 79 Akt Activator: Empowering Neuroprotection and Cancer R
2026-05-12
SC 79 stands out as a potent, cytosol-selective Akt activator, enabling precise control of survival signaling in both neuroscience and cancer models. Its unique mechanism and robust neuroprotection make it a go-to tool for dissecting the PI3K/Akt pathway, with proven value in both bench research and translational workflows.
-
RSL3: Glutathione Peroxidase 4 Inhibitor for Ferroptosis Res
2026-05-12
RSL3, a potent and selective GPX4 inhibitor, has become a cornerstone tool for dissecting ferroptosis and oxidative stress in cancer biology. Its unique synthetic lethality in RAS-driven tumors and ability to modulate radiosensitivity open new experimental and translational frontiers for targeted cancer research.
-
TCF25 Regulates Lysosomal Acidification and Cell Fate in Glu
2026-05-11
The study by Ren et al. identifies TCF25 as a pivotal nutrient sensor that orchestrates metabolic adaptation and cell death during glucose deprivation by enhancing lysosomal acidification through V-ATPase. These findings provide new insight into the regulation of autophagy, iron metabolism, and lysosome-dependent cell death, revealing potential therapeutic targets for metabolic and ischemic disorders.
-
Uridine, Trisodium Salt: Optimizing RNA Biosynthesis Workflo
2026-05-11
Uridine, Trisodium Salt empowers researchers to achieve high-fidelity RNA biosynthesis and precise vascular response assays. This article delivers actionable protocols, troubleshooting advice, and unique workflow enhancements inspired by the latest RNA-mediated genome engineering breakthroughs.
-
Innovative In Vitro Methods to Evaluate Anti-Cancer Drug Res
2026-05-10
Schwartz's dissertation advances in vitro drug response evaluation by distinguishing between proliferative arrest and cell death in cancer assays. This work provides a more nuanced framework for interpreting drug effects, with practical implications for optimizing DNA topoisomerase II inhibitor research and DNA replication studies.
-
Cimetidine in Translational Cancer Research: BBB Models & H2
2026-05-09
Explore the multifaceted role of Cimetidine as a histamine-2 receptor antagonist in cancer research, with a novel focus on blood-brain barrier models and mechanistic H2R signaling. This comprehensive review offers unique assay guidance and comparative analysis distinct from standard protocols.
-
Benzyl-activated Streptavidin Magnetic Beads: Precision in B
2026-05-08
APExBIO's Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) deliver unmatched specificity and workflow control for isolating biotinylated molecules in advanced protein and nucleic acid assays. This guide dives deep into applied protocols, troubleshooting, and innovations bridging immunoprecipitation, drug screening, and tumor microenvironment studies.
-
Thapsigargin in Neurodegenerative Disease Models: Precision
2026-05-08
Explore Thapsigargin’s unparalleled role as a SERCA pump inhibitor in neurodegenerative disease models and advanced endoplasmic reticulum stress research. This article delivers deeper mechanistic insights and protocol guidance for apoptosis assays, setting it apart from existing resources.
-
FXR-KLF11 Axis Suppresses JAK2/STAT3 to Mitigate CI-AKI
2026-05-07
This study elucidates how FXR activation upregulates KLF11, resulting in suppressed JAK2/STAT3 signaling and protection against contrast-induced acute kidney injury (CI-AKI). The work advances mechanistic understanding of inflammation in renal pathology and demonstrates a direct transcriptional regulation pathway with translational implications for inflammation research.
-
PPZ1-TORC1 Pathway Links Ferroptosis to Antifungal Resistanc
2026-05-07
This study uncovers how the fungus-specific PPZ1-TORC1 pathway regulates ferroptosis and antifungal drug resistance in Candida albicans. By establishing the mechanistic role of lipid peroxidation in fungal cell death, the work identifies a promising antifungal strategy and theoretical basis for targeting ferroptosis in pathogenic fungi.
-
Deferasirox Fe3+ Chelate: Precision in Iron Overload Researc
2026-05-06
Explore how Deferasirox Fe3+ chelate advances iron overload treatment research with unique insights into its chelation mechanism and practical assay guidance. Discover new dimensions in beta-thalassemia and chronic anemia modeling.
-
RNASEH1-AS1: Prognostic lncRNA and Oncogenic Target in HCC
2026-05-06
This study identifies the long non-coding RNA RNASEH1-AS1 as a robust prognostic biomarker and potential oncogenic driver in hepatocellular carcinoma (HCC). Through integrative bioinformatics and experimental validation, RNASEH1-AS1 is shown to correlate with advanced tumor features and poor outcomes, offering new avenues for biomarker-guided research and therapeutic targeting.
-
One-step TUNEL Cy3 Apoptosis Detection Kit: Applied Workflow
2026-05-05
The One-step TUNEL Cy3 Apoptosis Detection Kit streamlines high-sensitivity detection of apoptotic DNA fragmentation in both tissue sections and cultured cells. Its robust Cy3 fluorescence and single-tube protocol empower researchers to quantify apoptosis with exceptional reproducibility, even in challenging experimental contexts.